secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0000950170-24-064700
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dyne Therapeutics shareholders elect three Class I directors, ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Carlo Incerti, M.D. elected with 61,028,245 votes for, 8,752,856 withheld, 5,235,919 broker non-votes.
- Catherine Stehman-Breen, M.D. elected with 55,026,485 votes for, 14,325,362 withheld, 5,665,173 broker non-votes.
- John G. Cox elected with 69,763,860 votes for, 32,767 withheld, 5,220,393 broker non-votes.
- Ratification of Deloitte & Touche as independent auditor for FY2024 passed with 74,962,217 for, 12,377 against, 42,426 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000095017024064700/0000950170-24-064700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000095017024064700/dyn-20240522.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-064700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer